Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Consulting agrmnt Director departure Appointed COO Appointed director
|
Organicell Regenerative Medicine, Inc. (BPSR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/28/2023 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
08/25/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
08/14/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
08/09/2023 |
8-K
| Completion of Acquisition or Disposition of Assets Interactive Data |
08/01/2023 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
07/26/2023 |
8-K
| Quarterly results |
07/11/2023 |
8-K
| Quarterly results |
06/29/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/16/2023 |
10-Q
| Quarterly Report for the period ended April 30, 2023 |
06/09/2023 |
8-K
| Other Events Interactive Data |
06/06/2023 |
8-K
| Investor presentation |
05/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/21/2023 |
8-K
| Quarterly results |
03/17/2023 |
10-Q
| Quarterly Report for the period ended January 31, 2023 |
03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of March 6, 2023, by and between ORGANICELL REGENERATIVE MEDICINE, INC., a Nevada corporation, with headquarters located at 3321 College Avenue, Suite 246, Davie, FL 33314 , and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 . WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. The Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions s...",
"Promissory Note made in favor of AJB Capital Investments",
"Warrant issued to AJB Capital Investments" |
|
01/30/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
12/30/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
12/23/2022 |
8-K
| Quarterly results |
12/01/2022 |
8-K
| Quarterly results |
11/25/2022 |
8-K
| Quarterly results |
11/21/2022 |
8-K
| Quarterly results |
10/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/20/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
10/12/2022 |
8-K/A
| Investor presentation |
10/12/2022 |
8-K
| Investor presentation |
09/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/22/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
09/20/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/16/2022 |
SC 13D
| Greyt Ventures, LLC reports a 12.3% stake in ORGANICELL REGENERATIVE MEDICINE, INC. |
09/16/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
09/15/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/14/2022 |
10-Q
| Quarterly Report for the period ended July 31, 2022 |
09/13/2022 |
SC 13D
| Modi Bhupendra Kumar reports a 8.6% stake in ORGANICELL REGENERATIVE MEDICINE, INC. |
09/09/2022 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
|
|
|